New combo drug for cholesterol and blood pressure enters first human tests
NCT ID NCT07590167
First seen May 20, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This early-stage study will test a new experimental drug called AD-231 in 60 healthy adults aged 19 to 64. The goal is to see how the body processes the drug and whether it is safe when taken as a single pill versus taking its components separately. Participants will receive a single dose under fasting conditions and be monitored closely. No direct treatment benefit is expected, but the results will guide future studies for people with high cholesterol and high blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H Plus Yangji Hospita
Seoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.